Akeega Tablet, Film Coated
Product Images NDC 57894-050

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Akeega (NDC 57894-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Akeega 01)

Chemical structure of NIRAPARIB TOSYLATE MONOHYDRATE, shown with atomic bonds and molecular groups including a tosylate moiety and a water molecule of hydration (H2O).*

FDA Label Image

Chemical Structure (Akeega 02)

Chemical structure diagram showing the molecular formula of the active ingredient in AKEEGA, containing Niraparib Tosylate Monohydrate and Abiraterone Acetate. The diagram depicts the arrangement of atoms and bonds in the compound, including rings and functional groups such as pyridine and acetate.*

FDA Label Image

Figure 1 (Akeega 03)

A Kaplan-Meier survival curve showing the percentage of subjects without an event over time (months from randomization), comparing two groups: Placebo + AAP and Niraparib + AAP. The x-axis represents months from randomization, and the y-axis represents the percent of subjects without an event. The graph includes the number of subjects at risk over time for each group, with Placebo + AAP indicated by a solid line with open circles and Niraparib + AAP by a dashed line with filled triangles.*

FDA Label Image

Figure 2 (Akeega 04)

A Kaplan-Meier survival plot showing the percentage of subjects without event over months from randomization. The two groups compared are Placebo + AAP and Niraparib + AAP, with corresponding numbers of subjects at risk listed below the x-axis over a 48-month period.*

FDA Label Image

Principal Display Panel (100 mg / 500 mg Bottle Carton)

Packaging label for AKEEGA tablets, film-coated, containing 100 mg niraparib and 500 mg abiraterone acetate. The label indicates a package of 60 tablets, manufactured for Janssen Biotech, Inc., Horsham, PA, USA, and product of France. It includes storage instructions and warnings about handling by pregnant women.*

FDA Label Image

Principal Display Panel (50 mg / 500 mg Bottle Carton)

Label for Akeega tablets, containing 50 mg niraparib and 500 mg abiraterone acetate. The carton displays the Janssen Biotech, Inc. labeler, product origin as France, and a 60 count of film-coated tablets. Storage instructions and warnings regarding pregnancy and tablet handling are included, along with barcodes and dosage strength prominently shown in purple.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.